(Total Views: 305)
Posted On: 09/12/2019 9:22:50 AM
Post# of 154756
New Investor Presentation Uploaded on 8 Sep.
https://www.cytodyn.com/newsroom/presentations
Here are the updates that I found between this one and the previous one from 26 August.
1) 350 mg responder rate increased 1% from 70% to 71%
2) 700 mg responder rate decreased 1% from 88% to 87% from 19 weeks to 20 weeks
3) Revenue potential changed to '1H2020' from '2020'
4) 'GvHD Interim Results 1Q2020' changed to 'GvHD First Patient Injected 4Q2019'
5) Some 1H/2H were dropped from 2019 (no change since we are in 2H already).
https://www.cytodyn.com/newsroom/presentations
Here are the updates that I found between this one and the previous one from 26 August.
1) 350 mg responder rate increased 1% from 70% to 71%
2) 700 mg responder rate decreased 1% from 88% to 87% from 19 weeks to 20 weeks
3) Revenue potential changed to '1H2020' from '2020'
4) 'GvHD Interim Results 1Q2020' changed to 'GvHD First Patient Injected 4Q2019'
5) Some 1H/2H were dropped from 2019 (no change since we are in 2H already).
(3)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
